Report: Ranbaxy to expand presence in U.S., other markets
PLAINSBORO TOWNSHIP, N.J. — India-based drug maker Ranbaxy Labs is looking to expand sales in the U.S. market, according to published reports.
The Associated Press said Ranbaxy CEO Arun Sawhney announced his intentions to position the company where it will be first (or one of the first) on U.S. market with just-approved generic drugs, and also is working to expand generic sales in emerging markets, such as India, China, Brazil and Russia. "The U.S., as a total business, will remain the most important to us," Sawhney was quoted as saying.
Click here for the full report.